Express Pharma - Page 10 of 2011 - Express Pharma

Targeted therapies and improved diagnostics remain needs unmet in T2-low asthma

Akums Group enters into a partnership for European market expansion

Mankind Pharma and Innovent Biologics partner to license and commercialise Sintilimab

We, at OmniActive, invest over 10 per cent of the total outlay into R&D

30 years and counting …

Maharashtra Government appoints Rajesh Narvekar as FDA Commissioner

Biocon Biologics receives FDA approval for biosimilar YESINTEK

Express Pharma December 2024

Incubators and innovation hubs: Accelerating entrepreneurship in life sciences

Solving productivity challenges in Chemical R&D

Strengthening drug security through a resilient and affordable pharmaceutical supply chain

Lupin gains tentative USFDA nod for Sitagliptin and Metformin Hydrochloride Tablets

Granules’ net zero commitment approved by SBTi